NCT01386177View on ClinicalTrials.gov

Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Mood DisorderSubstance-Related DisordersAmphetamine-Related Disorders
Interventions
DRUG

3,4-Methylenedioxymethamphetamine

125 mg per os, single dose

DRUG

Doxazosin

"3 days (-64h) before MDMA: 4 mg doxazosin per os. 2 days (-40h) before MDMA: 8 mg doxazosin per os.~1 day (-16h) before MDMA: 8 mg doxazosin per os."

DRUG

placebo

capsules identical to MDMA or doxazosin

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT01386177 - Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA) | Biotech Hunter | Biotech Hunter